I64
Conditions
Interventions
Group 1: In SANO EXTEND, subjects who were included in the intervention group in the main SANO study are asked about their general state of health, quality of life (PHQ8, GAD 7, FACIT-fatigue Scale, P
Sponsors
Institut für Klinische Epidemiologie und Biometrie (IKE-B) der Universität Würzburg
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients who have participated in the SANO study and who have given their consent to the extended follow-up survey. Patient understands the contents of the study and can make the decision to participate in the study independently.
Exclusion criteria
Exclusion criteria: none
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Combined endpoint of recurrent stroke, myocardial infarction or death within five to six years after stroke | — |
Secondary
| Measure | Time frame |
|---|---|
| Rate of individual components of the primary endpoint Rate of transient ischemic attacks (TIAs) within five to six years after stroke Control of cardiovascular risk factors according to predefined targets based on clinical guidelines Functional outcome (mRS) after five to six years Drug treatment including prescription of antiplatelet or anticoagulant drugs Rate of readmission to hospital after five to six years Adequate provision of assistive devices and therapies Quality of life reported by patients (European Quality of Life 5 Dimensions (EQ-5D) and Patient Reported Outcomes Measurement Information System (PROMIS 29)) Rate of complications (cognitive impairment, depression and anxiety, fatigue, falls, etc.) and their guideline-compliant treatment | — |
Countries
Germany
Contacts
Public ContactLena Schmidbauer
Institut für Klinische Epidemiologie und Biometrie (IKE-B) der Universität Würzburg
Outcome results
None listed